Biologics Regulatory Top Stories Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products byTim AllenMay 8, 2024
Biologics Spine Top Stories PUR Biologics Announces Launch of PURcore™, a bioActive Moldable Synthetic for Spine Surgery byJosh SandbergApril 6, 2023
Biologics Extremities Top Stories Biogennix’s Agilon Moldable Bone Graft Solution Achieves Sales Surge Amid Adoption by Foot and Ankle Surgeons byJosh SandbergMay 19, 2021
Biologics Spine Surgalign Holdings Announce the Commercial Launch of ViBone® Moldable and the First Clinical Implantation byJosh SandbergJanuary 12, 2021
Biologics Regulatory Spine Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures byJosh SandbergMarch 4, 2020
